Variant report
Variant | esv275593 |
---|---|
Chromosome Location | chr20:15235424-15239469 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4473454 | chr20:15235424-15235425 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs189408271 | chr20:15235492-15235493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73614403 | chr20:15235503-15235504 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs549920480 | chr20:15235555-15235556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568379523 | chr20:15235600-15235601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75017119 | chr20:15235601-15235602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74179767 | chr20:15235608-15235609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73101205 | chr20:15235663-15235664 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs141512331 | chr20:15235698-15235699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369060583 | chr20:15235732-15235733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181822560 | chr20:15235773-15235774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547842167 | chr20:15235796-15235797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544026454 | chr20:15235805-15235806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73262749 | chr20:15235839-15235840 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs186184264 | chr20:15235850-15235851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529595431 | chr20:15235855-15235856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555362064 | chr20:15235881-15235882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576433957 | chr20:15235882-15235883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549427177 | chr20:15235917-15235918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150548314 | chr20:15235935-15235936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528477557 | chr20:15235973-15235974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149616884 | chr20:15236000-15236001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574026241 | chr20:15236004-15236005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190463197 | chr20:15236008-15236009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74179768 | chr20:15236079-15236080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7274642 | chr20:15236087-15236088 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs571936185 | chr20:15236092-15236093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7274602 | chr20:15236096-15236097 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs75721705 | chr20:15236128-15236129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571396134 | chr20:15236135-15236136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146111497 | chr20:15236153-15236154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140191684 | chr20:15236168-15236169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17297763 | chr20:15237211-15237212 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs553117104 | chr20:15237302-15237303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73101209 | chr20:15237376-15237377 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs73101210 | chr20:15237384-15237385 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs187402062 | chr20:15237385-15237386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543256281 | chr20:15237388-15237389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2223007 | chr20:15237413-15237414 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs56202220 | chr20:15237416-15237417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555508357 | chr20:15237420-15237421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573754088 | chr20:15237460-15237461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148517882 | chr20:15237474-15237475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559481746 | chr20:15237556-15237557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551356758 | chr20:15237573-15237574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113291571 | chr20:15237576-15237577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs117813844 | chr20:15237617-15237618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142796901 | chr20:15237676-15237677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530823171 | chr20:15237677-15237678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7262594 | chr20:15237689-15237690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
Multiple sclerosis | 20663923 | CNVD |
Schizophrenia | 20663923 | CNVD |
brain infarct | 20663923 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164920 | CNVD |
Schizophrenia | 23813976 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:15234000-15236000 | Weak transcription | Gastric | stomach |
2 | chr20:15236000-15236200 | Enhancers | Gastric | stomach |
3 | chr20:15237200-15238400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr20:15237600-15238400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr20:15237800-15238200 | Enhancers | HMEC | breast |